Status:
WITHDRAWN
Prospective Study Evaluating a Novel Mobile App Based Preventive Behavioral Intervention for Perinatal Mood Disorders
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Positive Intelligence Inc.
Conditions:
Perinatal Depression
Perinatal Anxiety
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The primary aim of the study is to investigate whether a novel mobile App-based behavioral intervention in pregnant women can: (1) prevent and/or decrease the incidence of perinatal mood disorders (2)...
Detailed Description
Perinatal depression is an episode of major or minor depression that occurs during pregnancy or in the 12 months after birth; it affects about 10% of new mothers. Postpartum depression accounts for 12...
Eligibility Criteria
Inclusion
- Able to read and speak English
- Have a low-risk singleton pregnancy with more than 24 weeks of gestation
- Have smartphone with internet access
- Failure to meet criteria for a diagnosis of MDD in the last two months
Exclusion
- Physical or mental disorders which would interfere with their ability to participate in the study
- High-risk pregnancy
- Give birth to a newborn at still-birth or a newborn with congenital anomalies and/or Medical complications that require special care in hospital
- Infant has a birth weight lower than 2,500 grams
- Infant has a 5-minute Apgar score lower than 7
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04914299
Start Date
July 1 2021
End Date
July 1 2022
Last Update
December 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.